Exam 1 Flashcards
Lotensin
benazepril
ACE-I, oral
Capoten
captopril
ACE-I, oral
Vasotec
enalapril
ACE-I, oral/IV(enalaprilat)
Monopril
fosinopril
ACE-I, oral
Zestril
lisinopril
ACE-I, oral
Univasc
moexipril
ACE-I, oral
ACE-I
angiotensin converting enzyme inhibitor
reduce angiotensin II levels, reduce vasoconstriction and aldosterone secretion, increase bradykinin
Edarbi
azilsartan
ARB, oral
Atacand
candesartan
ARB, oral
Teveten
eprosartan
ARB, oral
Avapro
irbesartan
ARB, oral
Cozaar
losartan
ARB, oral
Benicar
olmesartan
ARB, oral
Micardis
telmisartan
ARB, oral
Diovan
valsartan
ARB, oral
ARB
angiotensin receptor blocker
more selectively reduce the effects of angiotensin than ACE-I (block AT1-R) –> reduce vasoconstriction and aldosterone release. NO effect on bradykinin
Norvasc
amlodipine
DHP Ca channel blocker, oral
Cleviprex
clevidipine
DHP Ca channel blocker - 4th gen, IV
Cardizem
diltiazem
NDHP Ca channel blocker, oral/SR/IV
Plendil
felodipine
DHP Ca channel blocker, oral ER
DynaCirc
isradipine
DHP Ca channel blocker, oral/ER
Cardene
nicardipine
DHP Ca channel blocker, oral/SR/IV
Procardia
nifedipine
DHP Ca channel blocker, oral/ER
Sular
nisoldipine
DHP Ca channel blocker, oral ER
Calan/Isoptin
verapamil
NDHP Ca channel blocker, oral/SR/IV
Non-dihydropyridine Ca channel blocker
vasodilators (mostly in arterioles, not veins), non-selective block of L-type slow Ca channels in SA/AV nodes, cardiac myocytes, and vascular smooth muscle) –> reduce CO, HR, PVR, (dec contractility)
Dihydropyridine Ca channel blockers
vasodilators (mostly in arterioles, not veins), block vascular Ca channels more so than cardiac Ca channels –> reduce PVR (no decrease in venous return ~ no orthostatic HTN
Corgard
nadolol - 1st gen
non-selective beta blocker, oral
Levatol
penbutolol - 1st gen
non-selective beta blocker, oral
Visken
pindolol - 1st gen ISA
non-selective beta blocker, oral